Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
1 |
0001000 - Document - Document and Entity Information |
Network |
* |
* |
http://www.aurismedical.com/role/DocumentAndEntityInformation |
2 |
Implied Table |
Table |
* |
* |
implied:Table |
3 |
Document and Entity Information [Abstract] |
Abstract |
|
|
ears:DocumentandEntityInformationAbstract |
4 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
5 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
6 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
7 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
8 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
9 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
10 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
11 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
12 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
13 |
Entity Well-known Seasoned Issuer |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
14 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
15 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
16 |
1001000 - Statement - Consolidated Statement of Profit or Loss and Other Comprehensive Income (Loss) |
Network |
* |
* |
http://www.aurismedical.com/role/ConsolidatedStatementOfProfitOrLossAndOtherComprehensiveIncomeLoss |
17 |
Implied Table |
Table |
* |
* |
implied:Table |
18 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
19 |
Research and development |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
20 |
General and administrative |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GeneralAndAdministrativeExpense |
21 |
Operating loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
22 |
Interest income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InvestmentIncome |
23 |
Interest expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestExpense |
24 |
Foreign currency exchange loss, net |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss |
25 |
Revaluation gain from derivative financial instruments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsOnChangeInFairValueOfDerivatives |
26 |
Transaction costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FeeAndCommissionExpense |
27 |
Loss before tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
28 |
Income tax gain/(loss) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
29 |
Net loss attributable to owners of the Company |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
30 |
Other comprehensive income/(loss): |
Abstract |
|
|
ifrs-full:OtherComprehensiveIncomeAbstract |
31 |
Items that will never be reclassified to profit or loss |
Abstract |
|
|
ifrs-full:ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract |
32 |
Remeasurements of defined benefit liability, net of taxes of CHF 0 |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans |
33 |
Items that are or may be reclassified to profit or loss |
Abstract |
|
|
ifrs-full:ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract |
34 |
Foreign currency translation differences, net of taxes of CHF 0 |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation |
35 |
Other comprehensive income/(loss), net of taxes of CHF 0 |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
36 |
Total comprehensive loss attributable to owners of the Company |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
37 |
Basic and diluted loss per share (in chf per share) |
Concept (Share) |
For Period |
|
ifrs-full:BasicAndDilutedEarningsLossPerShare |
38 |
1001501 - Statement - Consolidated Statement of Profit or Loss and Other Comprehensive Income (Loss) (Parenthetical) |
Network |
* |
* |
http://www.aurismedical.com/role/ConsolidatedStatementOfProfitOrLossAndOtherComprehensiveIncomeLossParenthetical |
39 |
Implied Table |
Table |
* |
* |
implied:Table |
40 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
41 |
Remeasurement of defined benefit plans, tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome |
42 |
Foreign currency translation differences, tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome |
43 |
Income tax relating to components of other comprehensive income |
Concept (Monetary) |
For Period |
|
ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome |
44 |
1002000 - Statement - Consolidated Statement of Financial Position |
Network |
* |
* |
http://www.aurismedical.com/role/ConsolidatedStatementOfFinancialPosition |
45 |
Implied Table |
Table |
* |
* |
implied:Table |
46 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
47 |
ASSETS |
Abstract |
|
|
ifrs-full:AssetsAbstract |
48 |
Non-current assets |
Abstract |
|
|
ifrs-full:NoncurrentAssetsAbstract |
49 |
Property and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
50 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
51 |
Derivative financial instruments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DerivativeFinancialAssets |
52 |
Other non-current receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherNoncurrentReceivables |
53 |
Total non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
54 |
Current assets |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
55 |
Other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentReceivables |
56 |
Prepayments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepayments |
57 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
58 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
59 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
60 |
EQUITY AND LIABILITIES |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
61 |
Equity |
Abstract |
|
|
ifrs-full:EquityAbstract |
62 |
Share capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
63 |
Share premium |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:SharePremium |
64 |
Foreign currency translation reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads |
65 |
Accumulated deficit |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
66 |
Total shareholders' (deficit)/equity attributable to owners of the Company |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
67 |
Non-current liabilities |
Abstract |
|
|
ifrs-full:NoncurrentLiabilitiesAbstract |
68 |
Loan |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
69 |
Derivative financial instruments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentDerivativeFinancialLiabilities |
70 |
Employee benefit liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentProvisionsForEmployeeBenefits |
71 |
Deferred tax liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
72 |
Total non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
73 |
Current liabilities |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
74 |
Loan |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentPortionOfLongtermBorrowings |
75 |
Trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
76 |
Accrued expenses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
77 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
78 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
79 |
Total equity and liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
80 |
1003000 - Statement - Consolidated Statement of Changes in Equity |
Network |
* |
* |
http://www.aurismedical.com/role/ConsolidatedStatementOfChangesInEquity |
81 |
Statement of changes in equity [table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
82 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
83 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
84 |
Share Capital |
Member |
|
|
ifrs-full:IssuedCapitalMember |
85 |
Share Premium |
Member |
|
|
ifrs-full:SharePremiumMember |
86 |
Foreign Currency Translation Reserve |
Member |
|
|
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember |
87 |
Accumulated Deficit |
Member |
|
|
ifrs-full:RetainedEarningsMember |
88 |
Statement of changes in equity [line items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
89 |
Increase (Decrease) in Equity [Roll Forward] |
Abstract |
|
|
ears:IncreaseDecreaseinEquityRollForward |
90 |
Balance at beginning of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
91 |
Other comprehensive income/(loss): |
Abstract |
|
|
ifrs-full:OtherComprehensiveIncomeAbstract |
92 |
Net loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
93 |
Other comprehensive loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
94 |
Total comprehensive loss attributable to owners of the Company |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
95 |
Issue of bonus shares |
Concept (Monetary) |
For Period |
Credit |
ears:IncreaseDecreaseThroughIssueofBonusSharesEquity |
96 |
Issue of ordinary shares associated with Initial Public Offering (IPO) and follow-on offering |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
97 |
Reorganization of group structure |
Concept (Monetary) |
For Period |
Credit |
ears:ReorganizationOfGroupStructure |
98 |
Transaction costs |
Concept (Monetary) |
For Period |
Debit |
ears:ShareIssueRelatedCostsTransactionCosts |
99 |
Share issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
100 |
Share based payments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions |
101 |
Balance at end of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
102 |
1004000 - Statement - Consolidated Statement of Cash Flows |
Network |
* |
* |
http://www.aurismedical.com/role/ConsolidatedStatementOfCashFlows |
103 |
Implied Table |
Table |
* |
* |
implied:Table |
104 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
105 |
Cash flows from operating activities |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
106 |
Net loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
107 |
Adjustments for: |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
108 |
Depreciation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationExpense |
109 |
Unrealized foreign currency exchange loss, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains |
110 |
Net interest expense |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:AdjustmentsForInterestIncome |
111 |
Loss on disposal of property and equipment |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment |
112 |
Share based payments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
113 |
Transaction costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForFinanceCosts |
114 |
Employee benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities |
115 |
Revaluation gain derivative financial instruments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives |
116 |
Income tax gain |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncomeTaxExpense |
117 |
Adjustments to reconcile profit (loss) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForReconcileProfitLoss |
118 |
Changes in: |
Abstract |
|
|
ears:ChangesInOperatingAssetsandLiabilitiesAbstract |
119 |
Other receivables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables |
120 |
Prepayments |
Concept (Monetary) |
For Period |
Debit |
ears:AdjustmentsforDecreaseIncreaseinPrepayments |
121 |
Trade and other payables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables |
122 |
Accrued expenses |
Concept (Monetary) |
For Period |
Debit |
ears:AdjustmentsforIncreaseDecreaseinAccruals |
123 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
124 |
Cash flows from investing activities |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
125 |
Purchase of property and equipment |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
126 |
Purchase of intangibles |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities |
127 |
Proceeds from disposals of property and equipment |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
128 |
Interest received |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestReceivedClassifiedAsInvestingActivities |
129 |
Net cash from / (used) in investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
130 |
Cash flows from financing activities |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
131 |
Share issuance costs |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PaymentsForShareIssueCosts |
132 |
Proceeds from issue of loan with warrant |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
133 |
Proceeds from follow-on offering |
Concept (Monetary) |
For Period |
Debit |
ears:ProceedsfromIssuingSharesFollowOnOffering |
134 |
Proceeds from IPO, net of underwriting fees and IPO costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
135 |
Transaction costs |
Concept (Monetary) |
For Period |
Credit |
ears:PaymentsforFinanceCosts |
136 |
Repayment of loan |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities |
137 |
Share issuance costs IPO |
Concept (Monetary) |
For Period |
Credit |
ears:PaymentsforShareIssueCostsInitialPublicOffering |
138 |
Interest paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestPaidClassifiedAsFinancingActivities |
139 |
Net cash from financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
140 |
Net decrease in cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges |
141 |
Cash and cash equivalents at beginning of the period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
142 |
Net effect of currency translation on cash |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
143 |
Cash and cash equivalents at end of the period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
144 |
2101100 - Disclosure - Reporting entity |
Network |
* |
* |
http://www.aurismedical.com/role/ReportingEntity |
145 |
Implied Table |
Table |
* |
* |
implied:Table |
146 |
Corporate Information and Statement of IFRS Compliance [Abstract] |
Abstract |
|
|
ears:CorporateInformationandStatementofIFRSComplianceAbstract |
147 |
Reporting entity |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNotesAndOtherExplanatoryInformationExplanatory |
148 |
2104100 - Disclosure - Basis of preparation |
Network |
* |
* |
http://www.aurismedical.com/role/BasisOfPreparation |
149 |
Implied Table |
Table |
* |
* |
implied:Table |
150 |
Corporate Information and Statement of IFRS Compliance [Abstract] |
Abstract |
|
|
ears:CorporateInformationandStatementofIFRSComplianceAbstract |
151 |
Basis of preparation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory |
152 |
2107100 - Disclosure - Significant accounting policies |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPolicies |
153 |
Implied Table |
Table |
* |
* |
implied:Table |
154 |
Corporate Information and Statement of IFRS Compliance [Abstract] |
Abstract |
|
|
ears:CorporateInformationandStatementofIFRSComplianceAbstract |
155 |
Significant accounting policies |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
156 |
2110100 - Disclosure - New standards, amendments and interpretations adopted by the Group |
Network |
* |
* |
http://www.aurismedical.com/role/NewStandardsAmendmentsAndInterpretationsAdoptedByGroup |
157 |
Implied Table |
Table |
* |
* |
implied:Table |
158 |
Accounting Policies, Accounting Estimates And Errors [Abstract] |
Abstract |
|
|
ears:AccountingPoliciesAccountingEstimatesAndErrorsAbstract |
159 |
New standards, amendments and interpretations adopted by the Group |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations |
160 |
2113100 - Disclosure - Financial instruments and risk management |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagement |
161 |
Implied Table |
Table |
* |
* |
implied:Table |
162 |
Financial Instruments [Abstract] |
Abstract |
|
|
ears:FinancialInstrumentsAbstract |
163 |
Financial instruments and risk management |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
164 |
2116100 - Disclosure - Segment information |
Network |
* |
* |
http://www.aurismedical.com/role/SegmentInformation |
165 |
Implied Table |
Table |
* |
* |
implied:Table |
166 |
Operating Segments [Abstract] |
Abstract |
|
|
ears:OperatingSegmentsAbstract |
167 |
Segment information |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory |
168 |
2119100 - Disclosure - Property and equipment |
Network |
* |
* |
http://www.aurismedical.com/role/PropertyAndEquipment |
169 |
Implied Table |
Table |
* |
* |
implied:Table |
170 |
Property, plant and equipment [abstract] |
Abstract |
|
|
ifrs-full:PropertyPlantAndEquipmentAbstract |
171 |
Property and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
172 |
2122100 - Disclosure - Intangible assets |
Network |
* |
* |
http://www.aurismedical.com/role/IntangibleAssets |
173 |
Implied Table |
Table |
* |
* |
implied:Table |
174 |
Intangible Assets [Abstract] |
Abstract |
|
|
ears:IntangibleAssetsAbstract |
175 |
Disclosure of intangible assets [text block] |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsExplanatory |
176 |
2125100 - Disclosure - Other receivables |
Network |
* |
* |
http://www.aurismedical.com/role/OtherReceivables |
177 |
Implied Table |
Table |
* |
* |
implied:Table |
178 |
Trade and other receivables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
179 |
Other receivables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory |
180 |
2128100 - Disclosure - Prepayments |
Network |
* |
* |
http://www.aurismedical.com/role/Prepayments |
181 |
Implied Table |
Table |
* |
* |
implied:Table |
182 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
183 |
Prepayments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory |
184 |
2131100 - Disclosure - Cash and cash equivalents |
Network |
* |
* |
http://www.aurismedical.com/role/CashAndCashEquivalents |
185 |
Implied Table |
Table |
* |
* |
implied:Table |
186 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
187 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory |
188 |
2134100 - Disclosure - Capital and reserves |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReserves |
189 |
Implied Table |
Table |
* |
* |
implied:Table |
190 |
Share capital, reserves and other equity interest [Abstract] |
Abstract |
|
|
ears:SharecapitalreservesandotherequityinterestAbstract |
191 |
Capital and reserves |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
192 |
2137100 - Disclosure - Share based compensation |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensation |
193 |
Implied Table |
Table |
* |
* |
implied:Table |
194 |
Share-based payment arrangements [Abstract] |
Abstract |
|
|
ears:SharebasedpaymentarrangementsAbstract |
195 |
Share based compensation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory |
196 |
2140100 - Disclosure - Trade and other payables |
Network |
* |
* |
http://www.aurismedical.com/role/TradeAndOtherPayables |
197 |
Implied Table |
Table |
* |
* |
implied:Table |
198 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
199 |
Trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
200 |
2143100 - Disclosure - Accrued expenses |
Network |
* |
* |
http://www.aurismedical.com/role/AccruedExpenses |
201 |
Implied Table |
Table |
* |
* |
implied:Table |
202 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
203 |
Accrued expenses |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory |
204 |
2146100 - Disclosure - Research and development expense |
Network |
* |
* |
http://www.aurismedical.com/role/ResearchAndDevelopmentExpense |
205 |
Implied Table |
Table |
* |
* |
implied:Table |
206 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
207 |
Research and development expense |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory |
208 |
2149100 - Disclosure - General and administrative expense |
Network |
* |
* |
http://www.aurismedical.com/role/GeneralAndAdministrativeExpense |
209 |
Implied Table |
Table |
* |
* |
implied:Table |
210 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
211 |
General and administrative expense |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory |
212 |
2152100 - Disclosure - Employee benefits |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefits |
213 |
Implied Table |
Table |
* |
* |
implied:Table |
214 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
215 |
Employee benefits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEmployeeBenefitsExplanatory |
216 |
2155100 - Disclosure - Finance income and finance expense |
Network |
* |
* |
http://www.aurismedical.com/role/FinanceIncomeAndFinanceExpense |
217 |
Implied Table |
Table |
* |
* |
implied:Table |
218 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
219 |
Finance income and finance expense |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory |
220 |
2158100 - Disclosure - Taxation |
Network |
* |
* |
http://www.aurismedical.com/role/Taxation |
221 |
Implied Table |
Table |
* |
* |
implied:Table |
222 |
Income Taxes [Abstract] |
Abstract |
|
|
ears:IncomeTaxesAbstract |
223 |
Taxation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
224 |
2161100 - Disclosure - Loss per share |
Network |
* |
* |
http://www.aurismedical.com/role/LossPerShare |
225 |
Implied Table |
Table |
* |
* |
implied:Table |
226 |
Earnings per share [abstract] |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
227 |
Disclosure of earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
228 |
2164100 - Disclosure - Commitments and contingencies |
Network |
* |
* |
http://www.aurismedical.com/role/CommitmentsAndContingencies |
229 |
Implied Table |
Table |
* |
* |
implied:Table |
230 |
Leases1 [Abstract] |
Abstract |
|
|
ears:Leases1Abstract |
231 |
Commitment and contingencies |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory |
232 |
2167100 - Disclosure - Loan and warrant |
Network |
* |
* |
http://www.aurismedical.com/role/LoanAndWarrant |
233 |
Implied Table |
Table |
* |
* |
implied:Table |
234 |
Financial Instruments [Abstract] |
Abstract |
|
|
ears:FinancialInstrumentsAbstract |
235 |
Loan and Warrant |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBorrowingsExplanatory |
236 |
2170100 - Disclosure - Related party transactions |
Network |
* |
* |
http://www.aurismedical.com/role/RelatedPartyTransactions |
237 |
Implied Table |
Table |
* |
* |
implied:Table |
238 |
Related Party [Abstract] |
Abstract |
|
|
ears:RelatedPartyAbstract |
239 |
Related party transactions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
240 |
2173100 - Disclosure - Warrants from Public Offering |
Network |
* |
* |
http://www.aurismedical.com/role/WarrantsFromPublicOffering |
241 |
Implied Table |
Table |
* |
* |
implied:Table |
242 |
Share capital, reserves and other equity interest [Abstract] |
Abstract |
|
|
ears:SharecapitalreservesandotherequityinterestAbstract |
243 |
Warrants from Public Offering |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofWarrantsTextBlock |
244 |
2174100 - Disclosure - Events after the balance sheet date |
Network |
* |
* |
http://www.aurismedical.com/role/EventsAfterBalanceSheetDate |
245 |
Implied Table |
Table |
* |
* |
implied:Table |
246 |
Events After Reporting Period [Abstract] |
Abstract |
|
|
ears:EventsAfterReportingPeriodAbstract |
247 |
Events after balance sheet date |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
248 |
2207201 - Disclosure - Significant accounting policies (Policies) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesPolicies |
249 |
Implied Table |
Table |
* |
* |
implied:Table |
250 |
Corporate Information and Statement of IFRS Compliance [Abstract] |
Abstract |
|
|
ears:CorporateInformationandStatementofIFRSComplianceAbstract |
251 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
ears:ConsolidationPolicy1PolicyTextBlock |
252 |
Segment reporting |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
253 |
Foreign currency |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
254 |
Property and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
255 |
Intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory |
256 |
Impairment of non-financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory |
257 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
258 |
Impairment of non-derivative financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory |
259 |
Derivative Financial Instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory |
260 |
Income tax |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory |
261 |
Employee benefits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory |
262 |
Considering reorganization / Merger |
Concept (Text Block (HTML)) |
For Period |
|
ears:DescriptionOfAccountingPolicyForReorganizationPolicyTextBlock |
263 |
Share-based compensation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
264 |
Provisions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory |
265 |
Leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory |
266 |
Earnings/(loss) per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
267 |
Statement of compliance |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:StatementOfIFRSCompliance |
268 |
Basis of measurement |
Concept (Text Block (HTML)) |
For Period |
|
ears:BasisofPresentationPolicyPolicyTextBlock |
269 |
Use of estimates and judgments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements |
270 |
Development expenditures |
Concept (Text Block (HTML)) |
For Period |
|
ears:DevelopmentExpendituresPolicyPolicyTextBlock |
271 |
2307302 - Disclosure - Significant accounting policies (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesTables |
272 |
Implied Table |
Table |
* |
* |
implied:Table |
273 |
Corporate Information and Statement of IFRS Compliance [Abstract] |
Abstract |
|
|
ears:CorporateInformationandStatementofIFRSComplianceAbstract |
274 |
Disclosure of closing and average exchange rates for the most significant foreign currencies |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureOfDetailedInformationAboutForeignCurrencyRatesExplanatoryTableTextBlock |
275 |
Disclosure of applicable estimated useful lives |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory |
276 |
2310301 - Disclosure - New standards, amendments and interpretations adopted by the Group (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/NewStandardsAmendmentsAndInterpretationsAdoptedByGroupTables |
277 |
Implied Table |
Table |
* |
* |
implied:Table |
278 |
Accounting Policies, Accounting Estimates And Errors [Abstract] |
Abstract |
|
|
ears:AccountingPoliciesAccountingEstimatesAndErrorsAbstract |
279 |
Disclosure of initial application of standards or interpretations |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations |
280 |
2313301 - Disclosure - Financial instruments and risk management (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementTables |
281 |
Implied Table |
Table |
* |
* |
implied:Table |
282 |
Financial Instruments [Abstract] |
Abstract |
|
|
ears:FinancialInstrumentsAbstract |
283 |
Disclosure of the carrying amounts of financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialAssetsExplanatory |
284 |
Disclosure of the carrying amounts of financial liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory |
285 |
Disclosure of remaining contractual maturities of non-derivative financial liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities |
286 |
Disclosure of remaining contractual maturities of derivative financial liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities |
287 |
Disclosure of fair value measurement of liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory |
288 |
Disclosure of maximum exposure to credit risk |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCreditRiskExposureExplanatory |
289 |
Disclosure of quantitative data about the exposure of financial assets and liabilities to currency risk |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory |
290 |
2316301 - Disclosure - Segment information (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/SegmentInformationTables |
291 |
Implied Table |
Table |
* |
* |
implied:Table |
292 |
Operating Segments [Abstract] |
Abstract |
|
|
ears:OperatingSegmentsAbstract |
293 |
Disclosure of operating segments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOperatingSegmentsExplanatory |
294 |
2319301 - Disclosure - Property and equipment (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/PropertyAndEquipmentTables |
295 |
Implied Table |
Table |
* |
* |
implied:Table |
296 |
Property, plant and equipment [abstract] |
Abstract |
|
|
ifrs-full:PropertyPlantAndEquipmentAbstract |
297 |
Disclosure of detailed information about property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory |
298 |
2322301 - Disclosure - Intangible assets (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/IntangibleAssetsTables |
299 |
Implied Table |
Table |
* |
* |
implied:Table |
300 |
Intangible Assets [Abstract] |
Abstract |
|
|
ears:IntangibleAssetsAbstract |
301 |
Disclosure of detailed information about intangible assets [text block] |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory |
302 |
2325301 - Disclosure - Other receivables (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/OtherReceivablesTables |
303 |
Implied Table |
Table |
* |
* |
implied:Table |
304 |
Trade and other receivables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
305 |
Disclosure of Other Receivables |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofOtherReceivablesTableTextBlock |
306 |
2328301 - Disclosure - Prepayments (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/PrepaymentsTables |
307 |
Implied Table |
Table |
* |
* |
implied:Table |
308 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
309 |
Disclosure of Prepayments |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofPrepaymentsTableTextBlock |
310 |
2331301 - Disclosure - Cash and cash equivalents (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/CashAndCashEquivalentsTables |
311 |
Implied Table |
Table |
* |
* |
implied:Table |
312 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
313 |
Disclosure of Detailed Information for Cash and Cash Equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofDetailedInformationforCashandCashEquivalentsTableTextBlock |
314 |
2334301 - Disclosure - Capital and reserves (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesTables |
315 |
Implied Table |
Table |
* |
* |
implied:Table |
316 |
Share capital, reserves and other equity interest [Abstract] |
Abstract |
|
|
ears:SharecapitalreservesandotherequityinterestAbstract |
317 |
Disclosure of issued share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
318 |
2337301 - Disclosure - Share based compensation (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensationTables |
319 |
Implied Table |
Table |
* |
* |
implied:Table |
320 |
Share-based payment arrangements [Abstract] |
Abstract |
|
|
ears:SharebasedpaymentarrangementsAbstract |
321 |
Disclosure of key terms and conditions related to grants |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory |
322 |
Disclosure of the fair value of options measured based on the Black-Scholes formula |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory |
323 |
Disclosure of the number and weighted average exercise prices of options |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory |
324 |
2340301 - Disclosure - Trade and other payables (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/TradeAndOtherPayablesTables |
325 |
Implied Table |
Table |
* |
* |
implied:Table |
326 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
327 |
Components of trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
ears:ComponentsofTradeandOtherPayablesTableTextBlock |
328 |
2343301 - Disclosure - Accrued expenses (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/AccruedExpensesTables |
329 |
Implied Table |
Table |
* |
* |
implied:Table |
330 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
331 |
Components of accrued expenses |
Concept (Text Block (HTML)) |
For Period |
|
ears:ComponentsofAccruedExpensesandOtherLiabilitiesTableTextBlock |
332 |
2346301 - Disclosure - Research and development expense (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/ResearchAndDevelopmentExpenseTables |
333 |
Implied Table |
Table |
* |
* |
implied:Table |
334 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
335 |
Components of research and development expense |
Concept (Text Block (HTML)) |
For Period |
|
ears:ComponentsofResearchandDevelopmentExpenseTableTextBlock |
336 |
2349301 - Disclosure - General and administrative expense (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/GeneralAndAdministrativeExpenseTables |
337 |
Implied Table |
Table |
* |
* |
implied:Table |
338 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
339 |
Components of general and administrative expense |
Concept (Text Block (HTML)) |
For Period |
|
ears:ComponentsofGeneralandAdministrativeExpenseTableTextBlock |
340 |
2352301 - Disclosure - Employee benefits (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsTables |
341 |
Implied Table |
Table |
* |
* |
implied:Table |
342 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
343 |
Disclosure of defined benefit plan expense recognized in profit or loss |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureOfDefinedBenefitPlanExpenseRecognizedInProfitOrLossExplanatoryTableTextBlock |
344 |
Disclosure of net defined benefit liability (asset) |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory |
345 |
Disclosure of defined benefit plans |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory |
346 |
Disclosure of sensitivity analysis for actuarial assumptions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory |
347 |
2355301 - Disclosure - Finance income and finance expense (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/FinanceIncomeAndFinanceExpenseTables |
348 |
Implied Table |
Table |
* |
* |
implied:Table |
349 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
350 |
Components of finance income (cost) |
Concept (Text Block (HTML)) |
For Period |
|
ears:ComponentsofFinanceIncomeCostTableTextBlock |
351 |
2358301 - Disclosure - Taxation (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationTables |
352 |
Implied Table |
Table |
* |
* |
implied:Table |
353 |
Income Taxes [Abstract] |
Abstract |
|
|
ears:IncomeTaxesAbstract |
354 |
Disclosure of income tax expense |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofIncomeTaxExpenseTableTextBlock |
355 |
Disclosure of major components of tax expense (income) |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofMajorComponentsofTaxExpenseIncomeTableTextBlock |
356 |
Disclosure of deferred taxes details |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofDeferredTaxesDetailsTableTextBlock |
357 |
Disclosure of temporary difference, unused tax losses and unused tax credits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory |
358 |
2361301 - Disclosure - Loss per share (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/LossPerShareTables |
359 |
Implied Table |
Table |
* |
* |
implied:Table |
360 |
Earnings per share [abstract] |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
361 |
Disclosure of earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofEarningsPerShareDetailsTableTextBlock |
362 |
2364301 - Disclosure - Commitments and contingencies (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/CommitmentsAndContingenciesTables |
363 |
Implied Table |
Table |
* |
* |
implied:Table |
364 |
Leases1 [Abstract] |
Abstract |
|
|
ears:Leases1Abstract |
365 |
Disclosure of maturity analysis of operating lease payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory |
366 |
2370301 - Disclosure - Related party transactions (Tables) |
Network |
* |
* |
http://www.aurismedical.com/role/RelatedPartyTransactionsTables |
367 |
Implied Table |
Table |
* |
* |
implied:Table |
368 |
Related Party [Abstract] |
Abstract |
|
|
ears:RelatedPartyAbstract |
369 |
Disclosure of compensation of key management and Board of Directors |
Concept (Text Block (HTML)) |
For Period |
|
ears:DisclosureofCompensationforKeyManagementPersonnelDetailsTableTextBlock |
370 |
2401401 - Disclosure - Reporting entity (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ReportingEntityDetails |
371 |
Disclosure of subsidiaries [table] |
Table |
* |
* |
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesTable |
372 |
Legal Entity [Axis] |
Axis |
|
|
dei:LegalEntityAxis |
373 |
Entity [Domain] |
Member |
|
|
dei:EntityDomain |
374 |
Auris Medical NewCo Holding AG |
Member |
|
|
ears:AurisMedicalNewCoHoldingAGMember |
375 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
376 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
377 |
Merger |
Member |
|
|
ifrs-full:MajorBusinessCombinationMember |
378 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
379 |
Subsidiaries [member] |
Member |
|
|
ifrs-full:SubsidiariesMember |
380 |
Auris Medical AG [Member] |
Member |
|
|
ears:AurisMedicalAGMember |
381 |
Otolanum AG [Member] |
Member |
|
|
ears:OtolanumAGMember |
382 |
Auris Medical Inc. [Member] |
Member |
|
|
ears:AurisMedicalInc.Member |
383 |
Auris Medical Ltd. [Member] |
Member |
|
|
ears:AurisMedicalLtd.Member |
384 |
Disclosure of subsidiaries [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
385 |
Proportion of ownership interest in subsidiary (as a percent) |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
386 |
Nominal share capital |
Concept (Monetary) |
As Of |
Credit |
ears:OwnershipInterestinSubsidiaryNominalShareCapital |
387 |
Share capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
388 |
Number of shares outstanding |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
389 |
Nominal value of common shares (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
390 |
Reverse stock split, conversion ratio, number of original shares held for 1 share in Auris NewCo |
Concept (Pure) |
For Period |
|
ears:ReverseShareSplitConversionRatio |
391 |
2404401 - Disclosure - Basis of preparation (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/BasisOfPreparationDetails |
392 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
393 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
394 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
395 |
Net operating loss (NOL) |
Member |
|
|
ifrs-full:UnusedTaxLossesMember |
396 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
397 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
398 |
2407403 - Disclosure - Significant accounting policies - Segment reporting (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesSegmentReportingNarrativeDetails |
399 |
Implied Table |
Table |
* |
* |
implied:Table |
400 |
Corporate Information and Statement of IFRS Compliance [Abstract] |
Abstract |
|
|
ears:CorporateInformationandStatementofIFRSComplianceAbstract |
401 |
Number of operating segments |
Concept (Integer) |
For Period |
|
ears:NumberOfOperatingSegments1 |
402 |
2407404 - Disclosure - Significant accounting policies - Disclosure of closing and average exchange rates for the most significant foreign currencies (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesDisclosureOfClosingAndAverageExchangeRatesForMostSignificantForeignCurrenciesDetails |
403 |
Disclosure of geographical areas [table] |
Table |
* |
* |
ifrs-full:DisclosureOfGeographicalAreasTable |
404 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
405 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
406 |
Switzerland |
Member |
|
|
ifrs-full:CountryOfDomicileMember |
407 |
United States |
Member |
|
|
country:US |
408 |
Europe |
Member |
|
|
ears:Europe1Member |
409 |
Disclosure of geographical areas [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfGeographicalAreasLineItems |
410 |
Reporting entities |
Concept (Integer) |
For Period |
|
ears:NumberOfReportingEntities |
411 |
Closing rate |
Concept (Decimal) |
As Of |
|
ifrs-full:ClosingForeignExchangeRate |
412 |
Average exchange rate |
Concept (Decimal) |
For Period |
|
ifrs-full:AverageForeignExchangeRate |
413 |
2407405 - Disclosure - Significant accounting policies - Disclosure of applicable estimated useful lives (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesDisclosureOfApplicableEstimatedUsefulLivesDetails |
414 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
415 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
416 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
417 |
Production equipment |
Member |
|
|
ears:ProductionEquipmentMember |
418 |
Office furniture and electronic data processing equipment (“EDP”) |
Member |
|
|
ifrs-full:OfficeEquipmentMember |
419 |
Leasehold improvements |
Member |
|
|
ifrs-full:LeaseholdImprovementsMember |
420 |
Disclosure of detailed information about property, plant and equipment [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
421 |
Useful life |
Concept (xbrli:durationItemType) |
For Period |
|
ears:UsefulLivesOrDepreciationRatesPropertyPlantAndEquipmentPeriod |
422 |
2407406 - Disclosure - Significant accounting policies - Intangible assets (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesIntangibleAssetsNarrativeDetails |
423 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
424 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
425 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
426 |
Licenses |
Member |
|
|
ifrs-full:LicencesMember |
427 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
428 |
Estimated useful life |
Concept (xbrli:durationItemType) |
For Period |
|
ears:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwillPeriod |
429 |
2407407 - Disclosure - Significant accounting policies - Share-based compensation (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/SignificantAccountingPoliciesShareBasedCompensationNarrativeDetails |
430 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
431 |
Title Of Individual1 [Axis] |
Axis |
|
|
ears:TitleOfIndividual1Axis |
432 |
Title Of Individual1 [Domain] |
Member |
|
|
ears:TitleOfIndividual1Domain |
433 |
Board of Directors |
Member |
|
|
ears:Director1Member |
434 |
Vesting1 [Axis] |
Axis |
|
|
ears:Vesting1Axis |
435 |
Vesting1 [Domain] |
Member |
|
|
ears:Vesting1Domain |
436 |
Tranche 1 |
Member |
|
|
ears:ShareBasedCompensationAwardTrancheOne1Member |
437 |
Tranche 2 |
Member |
|
|
ears:ShareBasedCompensationAwardTrancheTwo1Member |
438 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
439 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
440 |
Stock Option Plan A |
Member |
|
|
ears:StockOptionPlanAMember |
441 |
Stock Option Plan C |
Member |
|
|
ears:StockOptionPlanCMember |
442 |
Equity Incentive Plan |
Member |
|
|
ears:AurisMedicalHoldingAGLongTermEquityIncentivePlanMember |
443 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
444 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
ears:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod2 |
445 |
Vesting percentage |
Concept (Percent) |
For Period |
|
ears:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1 |
446 |
2413402 - Disclosure - Financial instruments and risk management - Disclosure of the carrying amounts of financial assets and liabilities (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementDisclosureOfCarryingAmountsOfFinancialAssetsAndLiabilitiesDetails |
447 |
Disclosure Of Financial Assets And Liabilities [Table] |
Table |
* |
* |
ears:DisclosureOfFinancialAssetsAndLiabilitiesTable |
448 |
Classes of financial assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialAssetsAxis |
449 |
Financial assets, class [member] |
Member |
|
|
ifrs-full:FinancialAssetsMember |
450 |
Cash and cash equivalents |
Member |
|
|
ears:CashAndCashEquivalents1Member |
451 |
Other receivables |
Member |
|
|
ears:OtherReceivablesMember |
452 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
453 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
454 |
Trade and other payables |
Member |
|
|
ears:TradeAndOtherPayablesMember |
455 |
Accrued expenses |
Member |
|
|
ears:AccruedExpensesMember |
456 |
Loan |
Member |
|
|
ears:Loans1Member |
457 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
458 |
Categories of financial liabilities [axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialLiabilitiesAxis |
459 |
Financial liabilities, category [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesCategoryMember |
460 |
At amortized cost |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember |
461 |
At fair value through profit and loss |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember |
462 |
Disclosure Of Financial Assets And Liabilities [Line Items] |
LineItems |
|
|
ears:DisclosureOfFinancialAssetsAndLiabilitiesLineItems |
463 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
464 |
Financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
465 |
2413403 - Disclosure - Financial instruments and risk management - Disclosure of remaining contractual maturities of financial liabilities (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementDisclosureOfRemainingContractualMaturitiesOfFinancialLiabilitiesDetails |
466 |
Disclosure Of Financial Assets And Liabilities [Table] |
Table |
* |
* |
ears:DisclosureOfFinancialAssetsAndLiabilitiesTable |
467 |
Categories of financial liabilities [axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialLiabilitiesAxis |
468 |
Financial liabilities, category [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesCategoryMember |
469 |
Carrying amount |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember |
470 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
471 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
472 |
Trade and other payables |
Member |
|
|
ears:TradeAndOtherPayablesMember |
473 |
Accrued expenses |
Member |
|
|
ears:AccruedExpensesMember |
474 |
Loan and borrowings |
Member |
|
|
ears:Loans1Member |
475 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
476 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
477 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
478 |
Less than 3 months |
Member |
|
|
ifrs-full:NotLaterThanThreeMonthsMember |
479 |
Between 3 months and 2 years |
Member |
|
|
ears:LaterThanThreeMonthsAndNotLaterThanTwoYearsMember |
480 |
2 years and later |
Member |
|
|
ears:LaterThanTwoYearsMember |
481 |
Disclosure Of Financial Assets And Liabilities [Line Items] |
LineItems |
|
|
ears:DisclosureOfFinancialAssetsAndLiabilitiesLineItems |
482 |
Non-derivative financial liabilities, undiscounted cash flows |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows |
483 |
Derivative financial liabilities, undiscounted cash flows |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows |
484 |
Total |
Concept (Monetary) |
As Of |
Credit |
ears:DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows |
485 |
2413404 - Disclosure - Financial instruments and risk management - Disclosure of fair value of derivative liabilities (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementDisclosureOfFairValueOfDerivativeLiabilitiesDetails |
486 |
Disclosure of fair value measurement of liabilities [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesTable |
487 |
Levels of fair value hierarchy [axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
488 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
489 |
Level 2 |
Member |
|
|
ifrs-full:Level2OfFairValueHierarchyMember |
490 |
Level 3 |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
491 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
492 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
493 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
494 |
Disclosure of fair value measurement of liabilities [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesLineItems |
495 |
Financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
496 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
497 |
2413405 - Disclosure - Financial instruments and risk management - Reconciliation of changes in fair value measurement, liabilities (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementReconciliationOfChangesInFairValueMeasurementLiabilitiesDetails |
498 |
Disclosure of fair value measurement of liabilities [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesTable |
499 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
500 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
501 |
At fair value |
Member |
|
|
ifrs-full:AtFairValueMember |
502 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
503 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
504 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
505 |
Loans |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
506 |
Disclosure of fair value measurement of liabilities [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesLineItems |
507 |
Reconciliation of changes in fair value measurement, liabilities [abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfChangesInFairValueMeasurementLiabilitiesAbstract |
508 |
Beginning Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
509 |
Financing cash flows |
Concept (Monetary) |
For Period |
Credit |
ears:IssuesSettlementsFairValueMeasurementLiabilities |
510 |
Fair value revaluation |
Concept (Monetary) |
For Period |
|
ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities |
511 |
Other changes |
Concept (Monetary) |
For Period |
Credit |
ears:OtherIncreaseDecreaseinFairValueMeasurementLiabilities |
512 |
Ending Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
513 |
2413406 - Disclosure - Financial instruments and risk management - Disclosure of maximum exposure to credit risk (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementDisclosureOfMaximumExposureToCreditRiskDetails |
514 |
Disclosure of credit risk exposure [table] |
Table |
* |
* |
ifrs-full:DisclosureOfCreditRiskExposureTable |
515 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
516 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
517 |
Credit risk [member] |
Member |
|
|
ifrs-full:CreditRiskMember |
518 |
Classes of financial instruments [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialInstrumentsAxis |
519 |
Financial instruments, class [member] |
Member |
|
|
ifrs-full:ClassesOfFinancialInstrumentsMember |
520 |
Cash and cash equivalents |
Member |
|
|
ears:CashAndCashEquivalents1Member |
521 |
Other receivables |
Member |
|
|
ears:OtherReceivablesMember |
522 |
Disclosure of credit risk exposure [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfCreditRiskExposureLineItems |
523 |
Maximum exposure to credit risk |
Concept (Monetary) |
As Of |
|
ifrs-full:MaximumExposureToCreditRisk |
524 |
2413407 - Disclosure - Financial instruments and risk management - Disclosure of quantitative data about the exposure of financial assets and liabilities to currency risk (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementDisclosureOfQuantitativeDataAboutExposureOfFinancialAssetsAndLiabilitiesToCurrencyRiskDetails |
525 |
Disclosure of nature and extent of risks arising from financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable |
526 |
Classes of financial instruments [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialInstrumentsAxis |
527 |
Financial instruments, class [member] |
Member |
|
|
ifrs-full:ClassesOfFinancialInstrumentsMember |
528 |
Cash and cash equivalents |
Member |
|
|
ears:CashAndCashEquivalents1Member |
529 |
Trade and other payables |
Member |
|
|
ears:TradeAndOtherPayablesMember |
530 |
Accrued expenses |
Member |
|
|
ears:AccruedExpensesMember |
531 |
Loan and borrowings |
Member |
|
|
ears:Loans1Member |
532 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
533 |
Currency1 [Axis] |
Axis |
|
|
ears:Currency1Axis |
534 |
Currency1 [Domain] |
Member |
|
|
ears:Currency1Domain |
535 |
USD |
Member |
|
|
currency:USD |
536 |
EUR |
Member |
|
|
currency:EUR |
537 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
538 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
539 |
Currency risk |
Member |
|
|
ifrs-full:CurrencyRiskMember |
540 |
Disclosure of nature and extent of risks arising from financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems |
541 |
Net statement of financial position exposure -asset/(liability) |
Concept (Monetary) |
As Of |
|
ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic |
542 |
2413408 - Disclosure - Financial instruments and risk management - Narrative (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinancialInstrumentsAndRiskManagementNarrativeDetails |
543 |
Disclosure of nature and extent of risks arising from financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable |
544 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
545 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
546 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
547 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
548 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
549 |
Floating interest rate |
Member |
|
|
ifrs-full:FloatingInterestRateMember |
550 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
551 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
552 |
Secured term loan facility |
Member |
|
|
ears:LoanAndSecurityAgreementSecuredTermLoanFacilityWithHerculesCapitalInc.Member |
553 |
Currency1 [Axis] |
Axis |
|
|
ears:Currency1Axis |
554 |
Currency1 [Domain] |
Member |
|
|
ears:Currency1Domain |
555 |
USD |
Member |
|
|
currency:USD |
556 |
EUR |
Member |
|
|
currency:EUR |
557 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
558 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
559 |
Currency risk |
Member |
|
|
ifrs-full:CurrencyRiskMember |
560 |
Interest rate risk |
Member |
|
|
ifrs-full:InterestRateRiskMember |
561 |
Disclosure of nature and extent of risks arising from financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems |
562 |
Increase or decrease in rate (as a percent) |
Concept (Percent) |
For Period |
|
ears:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariablePercent |
563 |
Impact of increase or decrease in rate on net result |
Concept (Monetary) |
For Period |
Credit |
ears:SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnPreTaxEarnings |
564 |
Term loan facility (up to) |
Concept (Monetary) |
As Of |
Credit |
ears:LineofCreditFacilityMaximumBorrowingCapacity1 |
565 |
Drawn on term loan facility |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
566 |
Interest rate per annum (as a percent) |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
567 |
2416402 - Disclosure - Segment information (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/SegmentInformationDetails |
568 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
569 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
570 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
571 |
Switzerland |
Member |
|
|
country:CH |
572 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
573 |
Non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
574 |
2419402 - Disclosure - Property and equipment (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/PropertyAndEquipmentDetails |
575 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
576 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
577 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
578 |
Production equipment |
Member |
|
|
ifrs-full:MachineryMember |
579 |
Office furniture and EDP |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
580 |
Leasehold improvements |
Member |
|
|
ifrs-full:LeaseholdImprovementsMember |
581 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
582 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
583 |
At cost |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
584 |
Accumulated depreciation |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
585 |
Disclosure of detailed information about property, plant and equipment [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
586 |
Reconciliation of changes in property, plant and equipment [abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract |
587 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
588 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
589 |
Disposals |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsPropertyPlantAndEquipment |
590 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
591 |
2422402 - Disclosure - Intangible assets (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/IntangibleAssetsDetails |
592 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
593 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
594 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
595 |
Licenses |
Member |
|
|
ifrs-full:LicencesMember |
596 |
IP & Data rights |
Member |
|
|
ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember |
597 |
Internally generated |
Member |
|
|
ifrs-full:InternallyGeneratedMember |
598 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
599 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
600 |
At cost |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
601 |
Accumulated amortization |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
602 |
Accumulated impairment losses |
Member |
|
|
ifrs-full:AccumulatedImpairmentMember |
603 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
604 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
605 |
Milestone payment intangible |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
606 |
Amortization expense |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
607 |
Impairment loss |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill |
608 |
Increase (decrease) through other changes, intangible assets other than goodwill |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill |
609 |
2425402 - Disclosure - Other receivables (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/OtherReceivablesDetails |
610 |
Implied Table |
Table |
* |
* |
implied:Table |
611 |
Trade and other receivables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
612 |
Value added tax receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentValueAddedTaxReceivables |
613 |
Withholding tax receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentReceivablesFromTaxesOtherThanIncomeTax |
614 |
Deposit credit cards |
Concept (Monetary) |
As Of |
Debit |
ears:CurrentReceivablesFromDepositCreditCards |
615 |
Other |
Concept (Monetary) |
As Of |
Debit |
ears:CurrentReceivablesFromOtherSources |
616 |
Total other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentReceivables |
617 |
2428402 - Disclosure - Prepayments (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/PrepaymentsDetails |
618 |
Implied Table |
Table |
* |
* |
implied:Table |
619 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
620 |
Advance payments to supplier |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAdvancesToSuppliers |
621 |
Insurance |
Concept (Monetary) |
As Of |
Debit |
ears:CurrentPrepaidInsurance |
622 |
Other |
Concept (Monetary) |
As Of |
Debit |
ears:OtherCurrentPrepayments |
623 |
Total prepayments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepayments |
624 |
2431402 - Disclosure - Cash and cash equivalents (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CashAndCashEquivalentsDetails |
625 |
Implied Table |
Table |
* |
* |
implied:Table |
626 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
627 |
Cash in bank accounts |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:BalancesWithBanks |
628 |
Cash on hand |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashOnHand |
629 |
Total cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
630 |
2434402 - Disclosure - Capital and reserves - Disclosure of issued share capital (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesDisclosureOfIssuedShareCapitalDetails |
631 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
632 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
633 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
634 |
Common shares nominal value |
Member |
|
|
ifrs-full:OrdinarySharesMember |
635 |
Sale Of Stock1 [Axis] |
Axis |
|
|
ears:SaleOfStock1Axis |
636 |
Sale Of Stock1 [Domain] |
Member |
|
|
ears:SaleOfStock1Domain |
637 |
Common shares issued for the follow-on offering |
Member |
|
|
ears:CommonSharesIssuedForTheFollowOnOfferingMember |
638 |
Issuance of Auris NewCo Shares |
Member |
|
|
ears:IssuanceOfAurisNewCoSharesMember |
639 |
Cancellation of Auris OldCo Shares |
Member |
|
|
ears:CancellationofAurisNewCoSharesMember |
640 |
Common shares issued for capital increase with a nominal value of CHF 0.02 each |
Member |
|
|
ears:CommonSharesIssuedForCapitalIncreaseMember |
641 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
642 |
Nominal value of common shares (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
643 |
Number (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
644 |
Value (CHF) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
645 |
Reconciliation of number of shares outstanding [abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfNumberOfSharesOutstandingAbstract |
646 |
Beginning balance (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
647 |
Common shares issued (in shares) |
Concept (Shares) |
For Period |
|
ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding |
648 |
Ending balance (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
649 |
2434403 - Disclosure - Capital and reserves - Follow-On Offering on Nasdaq Global Market (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesFollowOnOfferingOnNasdaqGlobalMarketNarrativeDetails |
650 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
651 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
652 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
653 |
Ordinary shares |
Member |
|
|
ifrs-full:OrdinarySharesMember |
654 |
Series A Warrants |
Member |
|
|
ears:SeriesAWarrantsMember |
655 |
Series B Warrants |
Member |
|
|
ears:SeriesBWarrantsMember |
656 |
Warrants |
Member |
|
|
ears:WarrantsMember |
657 |
Equity Offerings |
Member |
|
|
ears:EquityOfferingsMember |
658 |
Warrants |
Member |
|
|
ears:StockWarrantMember |
659 |
Sale Of Stock1 [Axis] |
Axis |
|
|
ears:SaleOfStock1Axis |
660 |
Sale Of Stock1 [Domain] |
Member |
|
|
ears:SaleOfStock1Domain |
661 |
A.G.P Sales Agreement |
Member |
|
|
ears:A.G.PSalesAgreementMember |
662 |
Common Shares [Member] |
Member |
|
|
ears:CommonSharesMember |
663 |
FiveT Capital AG |
Member |
|
|
ears:FiveTCapitalAGMember |
664 |
Commitment Purchase Agreement |
Member |
|
|
ears:CommitmentPurchaseAgreementMember |
665 |
2017 Commitment Purchas Agreement |
Member |
|
|
ears:A2017CommitmentPurchasAgreementMember |
666 |
2018 Commitment Purchase Agreement |
Member |
|
|
ears:A2018CommitmentPurchaseAgreementMember |
667 |
Public offering |
Member |
|
|
ears:PublicOfferingMember |
668 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
669 |
Nominal value (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
670 |
Common shares outstanding (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
671 |
Maximum subscribe of common shares |
Concept (Monetary) |
For Period |
Debit |
ears:MaximumSubscribeOfCommonShares |
672 |
Number of shares issued (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
673 |
Gross proceeds |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
674 |
Common shares issued (in shares) |
Concept (Shares) |
For Period |
|
ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding |
675 |
Nominal value per share (in CHF per share) |
Concept (Share) |
For Period |
|
ears:NominalValuePerShare |
676 |
Adjustments of transaction costs |
Concept (Monetary) |
For Period |
Debit |
ears:AdjustmentsOfTransactionCosts |
677 |
Purchase common shares fair value |
Concept (Monetary) |
For Period |
Debit |
ears:PurchaseCommonSharesFairValue |
678 |
Agreement term |
Concept (xbrli:durationItemType) |
For Period |
|
ears:ShareSubscriptionAgreementAgreementTerm |
679 |
Proceeds from issue of ordinary shares |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfOrdinaryShares |
680 |
Transaction costs |
Concept (Monetary) |
For Period |
Debit |
ears:TransactionCosts |
681 |
Non-current derivative financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentDerivativeFinancialAssets |
682 |
Finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
683 |
Issuance initial public offering (in shares) |
Concept (Shares) |
For Period |
|
ears:IssuanceInitialPublicOffering |
684 |
Warrants outstanding (in shares) |
Concept (Shares) |
For Period |
|
ears:WarrantsOutstanding |
685 |
Number of common shares exercisable through warrants, up to (in shares) |
Concept (Shares) |
For Period |
|
ears:NumberofSharesofCommonSharesExercisablebyWarrantsOutstanding |
686 |
Exercise price of warrants (in CHF per share) |
Concept (Share) |
For Period |
|
ears:WarrantsExercisePricePerCommonShare |
687 |
Issuance of common shares, transaction costs |
Concept (Monetary) |
For Period |
Debit |
ears:IssuanceOfCommonSharesTransactionCosts |
688 |
Share subscription agreement, subscription amount |
Concept (Monetary) |
As Of |
Credit |
ears:ShareSubscriptionAgreementSubscriptionAmount |
689 |
Transaction costs recognized in equity |
Concept (Monetary) |
For Period |
Debit |
ears:ShareIssueRelatedCostsTransactionCosts |
690 |
Transaction costs recognized in profit or loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FeeAndCommissionExpense |
691 |
Commitment fee |
Concept (Monetary) |
For Period |
Debit |
ears:CommitmentFeeExpense |
692 |
Commitment fee related to cash proceeds from issue of shares |
Concept (Monetary) |
For Period |
Debit |
ears:CommitmentFeeRelatedtoCashProceedsfromIssueofShares |
693 |
Derecognition of commitment fee |
Concept (Monetary) |
For Period |
Credit |
ears:CommitmentFeeDerecognitionAmount |
694 |
Conversion ratio |
Concept (Pure) |
For Period |
|
ears:ClassOfWarrantOrRightConversionRatio |
695 |
Share issue related cost |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
696 |
2434404 - Disclosure - Capital and reserves - Issuance of common shares with restrictions (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesIssuanceOfCommonSharesWithRestrictionsNarrativeDetails |
697 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
698 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
699 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
700 |
Restricted common shares |
Member |
|
|
ears:RestrictedSharesMember |
701 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
702 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
703 |
Equity Incentive Plan |
Member |
|
|
ears:AurisMedicalHoldingAGLongTermEquityIncentivePlanMember |
704 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
705 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
706 |
Common shares nominal value |
Member |
|
|
ifrs-full:OrdinarySharesMember |
707 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
708 |
Shares awarded and issued (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
709 |
Nominal value (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
710 |
Payroll charge |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
711 |
Common shares outstanding (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
712 |
2434405 - Disclosure - Capital and reserves - Controlled Equity Offering (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesControlledEquityOfferingNarrativeDetails |
713 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
714 |
Sale Of Stock1 [Axis] |
Axis |
|
|
ears:SaleOfStock1Axis |
715 |
Sale Of Stock1 [Domain] |
Member |
|
|
ears:SaleOfStock1Domain |
716 |
Sales Agreement |
Member |
|
|
ears:ControlledEquityOfferingSalesAgreementWithCantorFitzgeraldCo.Member |
717 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
718 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
719 |
Common shares nominal value |
Member |
|
|
ifrs-full:OrdinarySharesMember |
720 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
721 |
Nominal value (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
722 |
Aggregate offering price (up to) |
Concept (Monetary) |
For Period |
Credit |
ears:ControlledEquitySalesAgreementMaximumAggregateOfferingPrice |
723 |
2434406 - Disclosure - Capital and reserves - Authorized share capital (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesAuthorizedShareCapitalNarrativeDetails |
724 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
725 |
Title Of Individual1 [Axis] |
Axis |
|
|
ears:TitleOfIndividual1Axis |
726 |
Title Of Individual1 [Domain] |
Member |
|
|
ears:TitleOfIndividual1Domain |
727 |
Board of Directors |
Member |
|
|
ears:Director1Member |
728 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
729 |
Authorized capital |
Concept (Monetary) |
As Of |
Credit |
ears:SharesAuthorisedValue |
730 |
Registered shares (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesAuthorised |
731 |
Nominal value (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
732 |
2434407 - Disclosure - Capital and reserves - Conditional share capital (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CapitalAndReservesConditionalShareCapitalNarrativeDetails |
733 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
734 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
735 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
736 |
Execution of subscription rights |
Member |
|
|
ears:ExecutionOfSubscriptionRightsMember |
737 |
Execution of conversion rights in connection with warrants and convertible bondsexecution of conversion rights in connection with warrants and convertible bonds |
Member |
|
|
ears:ExecutionOfConversionRightsInConnectionWithWarrantsAndConvertibleBondsMember |
738 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
739 |
Issuance of fully paid registered Common Shares that may increase share capital (up to) (in shares) |
Concept (Shares) |
For Period |
|
ears:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesAvailableForGrant |
740 |
Nominal value (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
741 |
Maximum amount |
Concept (Monetary) |
For Period |
Credit |
ears:NumberOfInstrumentsGrantedInShareBasedPaymentArrangementMaximumAmount |
742 |
2437402 - Disclosure - Share based compensation - Description (Narrative) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensationDescriptionNarrativeDetails |
743 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
744 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
745 |
Intangible assets and goodwill |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
746 |
Intangible assets |
Member |
|
|
ifrs-full:IntangibleAssetsMaterialToEntityMember |
747 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
748 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
749 |
Options |
Member |
|
|
ears:EmployeeStockOption1Member |
750 |
Equity Incentive Plan |
Member |
|
|
ears:EquityIncentivePlanMember |
751 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
752 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
753 |
Stock Option Plan A |
Member |
|
|
ears:StockOptionPlanAMember |
754 |
Stock Option Plan C |
Member |
|
|
ears:StockOptionPlanCMember |
755 |
Stock Option Plan B |
Member |
|
|
ears:StockOptionPlanBMember |
756 |
Equity Incentive Plan |
Member |
|
|
ears:AurisMedicalHoldingAGLongTermEquityIncentivePlanMember |
757 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
758 |
Total expense recognized for equity-settled share-based payment transactions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
759 |
Share based payments costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
760 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
ears:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod |
761 |
Number of share options granted (in shares) |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
762 |
Period preceding the date of grant for the Board of Directors to define the exercise price |
Concept (xbrli:durationItemType) |
For Period |
|
ears:PeriodPrecedingDateOfGrantToDefineExercisePriceOfOptions |
763 |
2437403 - Disclosure - Share based compensation - Disclosure of key terms and conditions related to grants (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensationDisclosureOfKeyTermsAndConditionsRelatedToGrantsDetails |
764 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
765 |
Title Of Individual1 [Axis] |
Axis |
|
|
ears:TitleOfIndividual1Axis |
766 |
Title Of Individual1 [Domain] |
Member |
|
|
ears:TitleOfIndividual1Domain |
767 |
Board |
Member |
|
|
ears:Director1Member |
768 |
Employees/Board |
Member |
|
|
ears:DirectorsAndEmployeesMember |
769 |
Bettina Stubinski, the former Chief Medical Officer |
Member |
|
|
ears:BettinaStubinskiFormerChiefMedicalOfficerMember |
770 |
Vesting1 [Axis] |
Axis |
|
|
ears:Vesting1Axis |
771 |
Vesting1 [Domain] |
Member |
|
|
ears:Vesting1Domain |
772 |
Tranche 1 |
Member |
|
|
ears:ShareBasedCompensationAwardTrancheOne1Member |
773 |
Tranche 2 |
Member |
|
|
ears:ShareBasedCompensationAwardTrancheTwo1Member |
774 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
775 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
776 |
Stock option Plan C |
Member |
|
|
ears:StockOptionPlanCMember |
777 |
Equity Incentive Plan |
Member |
|
|
ears:AurisMedicalHoldingAGLongTermEquityIncentivePlanMember |
778 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
779 |
Number of options outstanding (in shares) |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
780 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
ears:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod |
781 |
Vesting percentage |
Concept (Percent) |
For Period |
|
ears:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1 |
782 |
Contractual life of options |
Concept (xbrli:durationItemType) |
For Period |
|
ears:OptionLifeShareOptionsGranted1 |
783 |
2437404 - Disclosure - Share based compensation - Disclosure of the fair value of options measured based on the Black-Scholes formula (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensationDisclosureOfFairValueOfOptionsMeasuredBasedOnBlackScholesFormulaDetails |
784 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
785 |
Vesting1 [Axis] |
Axis |
|
|
ears:Vesting1Axis |
786 |
Vesting1 [Domain] |
Member |
|
|
ears:Vesting1Domain |
787 |
Tranche 1 |
Member |
|
|
ears:ShareBasedCompensationAwardTrancheOne1Member |
788 |
Tranche 2 |
Member |
|
|
ears:ShareBasedCompensationAwardTrancheTwo1Member |
789 |
Title Of Individual1 [Axis] |
Axis |
|
|
ears:TitleOfIndividual1Axis |
790 |
Title Of Individual1 [Domain] |
Member |
|
|
ears:TitleOfIndividual1Domain |
791 |
Board of Directors |
Member |
|
|
ears:BoardofDirectorsMember |
792 |
Employees/Board |
Member |
|
|
ears:DirectorsAndEmployeesMember |
793 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
794 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
795 |
Equity Incentive Plan 2018 - October |
Member |
|
|
ears:EquityIncentivePlan2017OctoberMember |
796 |
Equity Incentive Plan 2018 - April |
Member |
|
|
ears:EquityIncentivePlan2017AprilMember |
797 |
Equity Incentive Plan 2017 - October |
Member |
|
|
ears:EquityIncentivePlan2016OctoberMember |
798 |
Equity Incentive Plan 2017 - April |
Member |
|
|
ears:EquityIncentivePlan2016AprilMember |
799 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
800 |
Share price at grant date (in USD per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageSharePriceShareOptionsGranted |
801 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
ears:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod |
802 |
Exercise price (in USD per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:ExercisePriceShareOptionsGranted |
803 |
Expected volatility (as a percent) |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted |
804 |
Expected dividends (as a percent) |
Concept (Percent) |
For Period |
|
ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted |
805 |
Risk-free interest rate |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted |
806 |
2437405 - Disclosure - Share based compensation - Disclosure of the number and weighted average exercise prices of options (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensationDisclosureOfNumberAndWeightedAverageExercisePricesOfOptionsDetails |
807 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
808 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
809 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
810 |
Reverse Stock Split |
Member |
|
|
ears:ReverseStockSplitMember |
811 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
812 |
Number of options |
Abstract |
|
|
ears:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstanding1RollForward |
813 |
Beginning balance (in shares) |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
814 |
Expired during the year (in shares) |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement |
815 |
Forfeited during the year (in shares) |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
816 |
Exercised during the year (in shares) |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
817 |
Granted during the year (in shares) |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
818 |
Ending balance (in shares) |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
819 |
Exercisable (in shares) |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
820 |
Weighted average exercise price |
Abstract |
|
|
ears:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1Abstract |
821 |
Beginning balance (in CHF per share) |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
822 |
Expired during the year (in CHF per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement |
823 |
Forfeited during the year (in CHF per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
824 |
Exercised during the year (in CHF per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
825 |
Granted during the year (in CHF per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
826 |
Ending balance (in CHF per share) |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
827 |
Exercisable (in CHF per share) |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
828 |
Weighted average remaining term |
Abstract |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract |
829 |
Beginning balance (term) |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
830 |
Granted during the year (term) |
Concept (Decimal) |
For Period |
|
ears:WeightedAverageRemainingContractualLifeOfShareOptionsGrantedDuringThePeriod |
831 |
Ending balance (term) |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
832 |
Exercisable (term) |
Concept (Decimal) |
As Of |
|
ears:WeightedAverageRemainingContractualLifeOfExercisableShareOptions |
833 |
2437406 - Disclosure - Share based compensation - Measurement of fair values (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ShareBasedCompensationMeasurementOfFairValuesDetails |
834 |
Disclosure of range of exercise prices of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable |
835 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
836 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
837 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
838 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
839 |
Disclosure of range of exercise prices of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems |
840 |
Exercise price for outstanding options (in CHF per share) |
Concept (Monetary) |
As Of |
|
ifrs-full:ExercisePriceOfOutstandingShareOptions |
841 |
2440402 - Disclosure - Trade and other payables (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TradeAndOtherPayablesDetails |
842 |
Implied Table |
Table |
* |
* |
implied:Table |
843 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
844 |
Trade accounts payable - third parties |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherPayablesToTradeSuppliers |
845 |
Other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentPayables |
846 |
Total trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
847 |
2443402 - Disclosure - Accrued expenses (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/AccruedExpensesDetails |
848 |
Implied Table |
Table |
* |
* |
implied:Table |
849 |
Subclassifications of assets, liabilities and equities [abstract] |
Abstract |
|
|
ifrs-full:SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract |
850 |
Accrued research and development costs including milestone payments |
Concept (Monetary) |
As Of |
Credit |
ears:CurrentResearchandDevelopmentProvision |
851 |
Professional fees |
Concept (Monetary) |
As Of |
Credit |
ears:CurrentProfessionalFeesAccruals |
852 |
Accrued vacation & overtime |
Concept (Monetary) |
As Of |
Credit |
ears:CurrentVacationandOvertimeAccruals |
853 |
Employee benefits incl. share based payments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermEmployeeBenefitsAccruals |
854 |
Other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentLiabilities |
855 |
Total accrued expenses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
856 |
2446402 - Disclosure - Research and development expense (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/ResearchAndDevelopmentExpenseDetails |
857 |
Implied Table |
Table |
* |
* |
implied:Table |
858 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
859 |
Pre-clinical projects |
Concept (Monetary) |
For Period |
Debit |
ears:PreClinicalExpense |
860 |
Clinical projects |
Concept (Monetary) |
For Period |
Debit |
ears:ClinicalExpense |
861 |
Drug manufacturing and substance |
Concept (Monetary) |
For Period |
Debit |
ears:ManufacturingExpense |
862 |
Employee benefits and expenses |
Concept (Monetary) |
For Period |
Debit |
ears:EmployeeBenefitsResearchandDevelopmentExpense |
863 |
Lease expenses |
Concept (Monetary) |
For Period |
Debit |
ears:ResearchandDevelopmentLeaseandSubleasePaymentsRecognisedasExpense |
864 |
Patents and trademarks |
Concept (Monetary) |
For Period |
Debit |
ears:PatentandTrademarksExpense |
865 |
Regulatory projects |
Concept (Monetary) |
For Period |
Debit |
ears:RegulatoryExpense |
866 |
Depreciation tangible assets |
Concept (Monetary) |
For Period |
Debit |
ears:DepreciationExpenseofResearchandDevelopmentTangibleAssets |
867 |
Total research and development expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
868 |
2449402 - Disclosure - General and administrative expense (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/GeneralAndAdministrativeExpenseDetails |
869 |
Implied Table |
Table |
* |
* |
implied:Table |
870 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
871 |
Employee benefits and expenses |
Concept (Monetary) |
For Period |
Debit |
ears:GeneralEmployeeBenefitsExpense |
872 |
Business development |
Concept (Monetary) |
For Period |
Debit |
ears:BusinessDevelopmentExpense |
873 |
Travel expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TravelExpense |
874 |
Administration expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdministrativeExpense |
875 |
Lease expenses |
Concept (Monetary) |
For Period |
Debit |
ears:GeneralLeaseandSubleasePaymentsRecognisedasExpense |
876 |
Depreciation tangible assets |
Concept (Monetary) |
For Period |
Debit |
ears:GeneralandAdministrativeDepreciationExpense |
877 |
Capital tax expenses |
Concept (Monetary) |
For Period |
Debit |
ears:CapitalTaxExpenseBenefit |
878 |
Total general and administrative expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GeneralAndAdministrativeExpense |
879 |
2452402 - Disclosure - Employee benefits - Expense recognized in statement of profit or loss (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsExpenseRecognizedInStatementOfProfitOrLossDetails |
880 |
Implied Table |
Table |
* |
* |
implied:Table |
881 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
882 |
Salaries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:WagesAndSalaries |
883 |
Pension costs |
Concept (Monetary) |
For Period |
Debit |
ears:PensionCosts |
884 |
Other social benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherShorttermEmployeeBenefits |
885 |
Share based payments costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
886 |
Recruitment costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProfessionalFeesExpense |
887 |
Other personnel expenditures |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherEmployeeExpense |
888 |
Total employee benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EmployeeBenefitsExpense |
889 |
2452403 - Disclosure - Employee benefits - Narrative (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsNarrativeDetails |
890 |
Implied Table |
Table |
* |
* |
implied:Table |
891 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
892 |
Minimum retirement saving interest rate (as a percent) |
Concept (Percent) |
As Of |
|
ears:ActuarialAssumptionsMinimumRetirementSavingInterestRate |
893 |
Weighted average duration of defined benefit obligation |
Concept (xbrli:durationItemType) |
For Period |
|
ears:WeightedAverageDurationofDefinedBenefitObligation1 |
894 |
2452404 - Disclosure - Employee benefits - Change in defined benefit obligation (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsChangeInDefinedBenefitObligationDetails |
895 |
Disclosure of net defined benefit liability (asset) [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetTable |
896 |
Net defined benefit liability (asset) [axis] |
Axis |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetAxis |
897 |
Net defined benefit liability (asset) [member] |
Member |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetMember |
898 |
Present value of funded defined benefit obligation |
Member |
|
|
ifrs-full:PresentValueOfDefinedBenefitObligationMember |
899 |
Disclosure of net defined benefit liability (asset) [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetLineItems |
900 |
Disclosure of net defined benefit liability (asset) [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetAbstract |
901 |
Defined benefit obligation at January 1 |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
902 |
Service costs |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset |
903 |
Plan participants' contribution |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset |
904 |
Interest cost |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset |
905 |
Actuarial losses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset |
906 |
Transfer-out amounts |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset |
907 |
Transfer-in amounts of new employees |
Concept (Monetary) |
For Period |
Credit |
ears:IncreaseDecreaseThroughTransfersInofNewEmployeesNetDefinedBenefitLiabilityAsset |
908 |
Defined benefit obligation at December 31 |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
909 |
2452405 - Disclosure - Employee benefits - Change in fair value of plan assets (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsChangeInFairValueOfPlanAssetsDetails |
910 |
Disclosure of net defined benefit liability (asset) [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetTable |
911 |
Net defined benefit liability (asset) [axis] |
Axis |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetAxis |
912 |
Net defined benefit liability (asset) [member] |
Member |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetMember |
913 |
Fair value of plan assets |
Member |
|
|
ifrs-full:PlanAssetsMember |
914 |
Disclosure of net defined benefit liability (asset) [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetLineItems |
915 |
Disclosure of net defined benefit liability (asset) [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetAbstract |
916 |
Fair value of plan assets at January 1 |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
917 |
Interest income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset |
918 |
Return on plan assets excluding interest income |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset |
919 |
Employer contributions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset |
920 |
Plan participants' contributions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset |
921 |
Transfer-out amounts |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset |
922 |
Transfer-in amounts of new employees |
Concept (Monetary) |
For Period |
Credit |
ears:IncreaseDecreaseThroughTransfersInofNewEmployeesNetDefinedBenefitLiabilityAsset |
923 |
Administration expense |
Concept (Monetary) |
For Period |
Credit |
ears:AdministrativeExpensesNetDefinedBenefitLiabilityAsset |
924 |
Fair value of plan assets at December 31 |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
925 |
2452406 - Disclosure - Employee benefits - Net defined benefit liability (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsNetDefinedBenefitLiabilityDetails |
926 |
Disclosure of net defined benefit liability (asset) [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetTable |
927 |
Net defined benefit liability (asset) [axis] |
Axis |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetAxis |
928 |
Net defined benefit liability (asset) [member] |
Member |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetMember |
929 |
Present value of funded defined benefit obligation |
Member |
|
|
ifrs-full:PresentValueOfDefinedBenefitObligationMember |
930 |
Fair value of plan assets |
Member |
|
|
ifrs-full:PlanAssetsMember |
931 |
Disclosure of net defined benefit liability (asset) [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetLineItems |
932 |
Net defined benefit liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
933 |
2452407 - Disclosure - Employee benefits - Defined benefit costs recognized in profit or loss (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsDefinedBenefitCostsRecognizedInProfitOrLossDetails |
934 |
Implied Table |
Table |
* |
* |
implied:Table |
935 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
936 |
Service costs |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset |
937 |
Net interest expense |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset |
938 |
Administration expense |
Concept (Monetary) |
For Period |
Credit |
ears:AdministrativeExpensesNetDefinedBenefitLiabilityAsset |
939 |
Total defined costs for the year recognized in profit or loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans |
940 |
2452408 - Disclosure - Employee benefits - Remeasurement of defined benefit liability (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsRemeasurementOfDefinedBenefitLiabilityDetails |
941 |
Implied Table |
Table |
* |
* |
implied:Table |
942 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
943 |
Actuarial loss (gain) arising from changes in financial assumptions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset |
944 |
Actuarial loss arising from experience adjustments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset |
945 |
Actuarial gain arising from demographic assumptions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset |
946 |
Return on plan assets excluding interest income |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset |
947 |
Total defined benefit cost for the year recognized in the other comprehensive loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans |
948 |
2452409 - Disclosure - Employee benefits - Assumptions (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsAssumptionsDetails |
949 |
Implied Table |
Table |
* |
* |
implied:Table |
950 |
Employee Benefits [Abstract] |
Abstract |
|
|
ears:EmployeeBenefitsAbstract |
951 |
Discount rate |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfDiscountRates |
952 |
Future salary increase |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases |
953 |
Pension indexation |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases |
954 |
2452410 - Disclosure - Employee benefits - Sensitivity Analysis (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EmployeeBenefitsSensitivityAnalysisDetails |
955 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
956 |
Actuarial assumptions [axis] |
Axis |
|
|
ifrs-full:ActuarialAssumptionsAxis |
957 |
Actuarial assumptions [member] |
Member |
|
|
ifrs-full:ActuarialAssumptionsMember |
958 |
Discount rate |
Member |
|
|
ifrs-full:ActuarialAssumptionOfDiscountRatesMember |
959 |
Salary increase |
Member |
|
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember |
960 |
Pension indexation |
Member |
|
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember |
961 |
Life expectancy |
Member |
|
|
ifrs-full:ActuarialAssumptionOfMortalityRatesMember |
962 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
963 |
Percentage of reasonably possible increase in actuarial assumption |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption |
964 |
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption |
965 |
Life expectancy reasonably possible increase in actuarial assumption |
Concept (xbrli:durationItemType) |
For Period |
|
ears:LifeExpectancyReasonablyPossibleIncreaseinActuarialAssumption |
966 |
2455402 - Disclosure - Finance income and finance expense - Components of finance income (expense) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinanceIncomeAndFinanceExpenseComponentsOfFinanceIncomeExpenseDetails |
967 |
Implied Table |
Table |
* |
* |
implied:Table |
968 |
Analysis of income and expense [abstract] |
Abstract |
|
|
ifrs-full:AnalysisOfIncomeAndExpenseAbstract |
969 |
Interest income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromInterest |
970 |
Net foreign currency exchange gain |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:NetForeignExchangeGain |
971 |
Revaluation gain from derivative financial instruments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsOnChangeInFairValueOfDerivatives |
972 |
Total finance income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
973 |
Interest expense (incl. Bank charges) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestExpense |
974 |
Net foreign currency exchange loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:NetForeignExchangeLoss |
975 |
Total finance expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
976 |
Finance income/(expense), net |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncomeCost |
977 |
2455403 - Disclosure - Finance income and finance expense - Narrative (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/FinanceIncomeAndFinanceExpenseNarrativeDetails |
978 |
Disclosure of Finance Income (Expense) [Table] |
Table |
* |
* |
ears:DisclosureofFinanceIncomeExpenseTable |
979 |
Currency [Axis] |
Axis |
|
|
ears:CurrenciesAxis |
980 |
Currency [Domain] |
Member |
|
|
ears:CurrenciesDomain |
981 |
USD and EUR denominated cash and cash equivalents |
Member |
|
|
ears:UnitedStatesDollarandEuroMember |
982 |
Disclosure of Finance Income (Expense) [Line Items] |
LineItems |
|
|
ears:DisclosureofFinanceIncomeExpenseLineItems |
983 |
Net foreign currency exchange gain |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:NetForeignExchangeGain |
984 |
Interest expense on borrowings |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestExpenseOnBorrowings |
985 |
2458402 - Disclosure - Taxation - Income tax provision (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationIncomeTaxProvisionDetails |
986 |
Implied Table |
Table |
* |
* |
implied:Table |
987 |
Income Taxes [Abstract] |
Abstract |
|
|
ears:IncomeTaxesAbstract |
988 |
Deferred income tax expense |
Concept (Monetary) |
For Period |
Debit |
ears:DeferredTaxExpenseandAdjustmentsforDeferredTax |
989 |
Deferred income tax gain |
Concept (Monetary) |
For Period |
Credit |
ears:DeferredTaxIncomeandAdjustmentsforDeferredTax |
990 |
Income tax gain |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
991 |
Average effective tax rate (as a percent) |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
992 |
2458403 - Disclosure - Taxation - Reconciliation of income tax expense (income) (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationReconciliationOfIncomeTaxExpenseIncomeDetails |
993 |
Implied Table |
Table |
* |
* |
implied:Table |
994 |
Income Taxes [Abstract] |
Abstract |
|
|
ears:IncomeTaxesAbstract |
995 |
Loss before income tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:AccountingProfit |
996 |
Income tax at statutory tax rates applicable to results in the respective countries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate |
997 |
Effect of unrecognized temporary differences |
Concept (Monetary) |
For Period |
Debit |
ears:TaxEffectofUnrecognisedTemporaryDifferences |
998 |
Effect of unrecognized taxable losses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxEffectOfTaxLosses |
999 |
Effect of previously unrecognised deferred tax asset |
Concept (Monetary) |
For Period |
Debit |
ears:TaxEffectofPreviouslyUnrecognisedDeferredTaxAssets |
1000 |
Effect of expenses deductible for tax purposes |
Concept (Monetary) |
For Period |
Credit |
ears:TaxEffectofExpenseDeductibleinDeterminingTaxableProfitTaxLoss |
1001 |
Effect of expenses not considerable for tax purposes |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss |
1002 |
Effect of impact from application of different tax rates |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxEffectOfForeignTaxRates |
1003 |
Effect of unrecognized taxable losses in equity |
Concept (Monetary) |
For Period |
Debit |
ears:TaxEffectofTaxLossesinEquity |
1004 |
Income tax gain |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
1005 |
2458404 - Disclosure - Taxation - Deferred tax assets and liabilities (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationDeferredTaxAssetsAndLiabilitiesDetails |
1006 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
1007 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
1008 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
1009 |
Intangible assets |
Member |
|
|
ears:IntangibleAssetsRelatedTemporaryDifferencesMember |
1010 |
Hercules Loan Facility |
Member |
|
|
ears:BorrowingandWarrantRelatedTemporaryDifferencesMember |
1011 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
1012 |
Net operating loss (NOL) |
Member |
|
|
ifrs-full:UnusedTaxLossesMember |
1013 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
1014 |
Deferred tax liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
1015 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
1016 |
Deferred tax liability (asset) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
1017 |
2458405 - Disclosure - Taxation - Deferred tax rollforward (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationDeferredTaxRollforwardDetails |
1018 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
1019 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
1020 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
1021 |
Intangible assets |
Member |
|
|
ears:IntangibleAssetsRelatedTemporaryDifferencesMember |
1022 |
Hercules Loan Facility |
Member |
|
|
ears:ProvisionRelatedTemporaryDifferencesMember |
1023 |
Hercules Loan Facility |
Member |
|
|
ears:BorrowingandWarrantRelatedTemporaryDifferencesMember |
1024 |
Derivative financial instruments |
Member |
|
|
ifrs-full:DerivativesMember |
1025 |
Net operating loss (NOL) |
Member |
|
|
ifrs-full:UnusedTaxLossesMember |
1026 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
1027 |
Reconciliation of changes in deferred tax liability (asset) [abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract |
1028 |
Opening Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
1029 |
Recognized in Profit or Loss |
Concept (Monetary) |
For Period |
|
ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss |
1030 |
Recognized in Equity |
Concept (Monetary) |
For Period |
|
ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity |
1031 |
Closing Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
1032 |
2458406 - Disclosure - Taxation - Unrecognized tax losses (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationUnrecognizedTaxLossesDetails |
1033 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
1034 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
1035 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
1036 |
Switzerland |
Member |
|
|
ifrs-full:CountryOfDomicileMember |
1037 |
United States |
Member |
|
|
ifrs-full:ForeignCountriesMember |
1038 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
1039 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
1040 |
Within one year |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
1041 |
Between 1 and 3 years |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
1042 |
Between 3 and 7 years |
Member |
|
|
ears:LaterThanTwoYearsandNotLaterThanSevenYearsMember |
1043 |
More than 7 years |
Member |
|
|
ears:LaterThanSevenYearsMember |
1044 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
1045 |
Tax loss carry forwards |
Concept (Monetary) |
As Of |
Debit |
ears:UnusedTaxLosses |
1046 |
2458407 - Disclosure - Taxation - Unrecognized deductible temporary differences and tax losses (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/TaxationUnrecognizedDeductibleTemporaryDifferencesAndTaxLossesDetails |
1047 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
1048 |
After Offset Amount, Offset Amount And Before Offset Amount [Axis] |
Axis |
|
|
ears:AfterOffsetAmountOffsetAmountAndBeforeOffsetAmountAxis |
1049 |
After Offset Amount, Offset Amount And Before Offset Amount [Domain] |
Member |
|
|
ears:AfterOffsetAmountOffsetAmountAndBeforeOffsetAmountDomain |
1050 |
Before Offset Amount |
Member |
|
|
ears:BeforeOffsetAmountMember |
1051 |
Offset Amount |
Member |
|
|
ears:OffsetAmountMember |
1052 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
1053 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
1054 |
Employee benefit plan |
Member |
|
|
ears:EmployeeBenefitPlanRelatedTemporaryDifferencesMember |
1055 |
Stock option plans |
Member |
|
|
ears:StockOptionPlanRelatedTemporaryDifferencesMember |
1056 |
Property and equipment |
Member |
|
|
ears:PropertyPlantandEquipmentRelatedTemporaryDifferencesMember |
1057 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
1058 |
Deductible temporary differences |
Concept (Monetary) |
As Of |
|
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised |
1059 |
Taxable unrecognized temporary differences |
Concept (Monetary) |
As Of |
Credit |
ears:TemporaryDifferencesNotDeductibleforWhichNoTaxLiabilityisRecognised |
1060 |
Offsetting potential tax liabilities with potential tax assets |
Concept (Monetary) |
As Of |
Debit |
ears:TemporaryDifferencesforWhichDeferredTaxAssetLiabilityisRecognised |
1061 |
Potential tax assets from loss carry-forwards not recognized |
Concept (Monetary) |
As Of |
|
ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised |
1062 |
Total potential tax assets from loss carry-forwards and temporary differences not recognized |
Concept (Monetary) |
As Of |
Credit |
ears:DeductibleTemporaryDifferencesandUnusedTaxLossesforWhichNoDeferredTaxAssetisRecognised |
1063 |
2461402 - Disclosure - Loss per share (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/LossPerShareDetails |
1064 |
Earnings per share [table] |
Table |
* |
* |
ifrs-full:EarningsPerShareTable |
1065 |
Antidilutive Securities [Axis] |
Axis |
|
|
ears:AntidilutiveSecuritiesAxis |
1066 |
Antidilutive Securities [Domain] |
Member |
|
|
ears:AntidilutiveSecuritiesDomain |
1067 |
Employee Stock Options |
Member |
|
|
ears:EmployeeStockOption1Member |
1068 |
Warrants |
Member |
|
|
ears:StockWarrantMember |
1069 |
Earnings per share [line items] |
LineItems |
|
|
ifrs-full:EarningsPerShareLineItems |
1070 |
Reverse-split ratio |
Concept (Pure) |
For Period |
|
ears:ReverseShareSplitConversionRatio |
1071 |
Options outstanding (in shares) |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
1072 |
Antidilutive securities excluded from computation of earnings per share (in shares) |
Concept (Shares) |
For Period |
|
ears:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount1 |
1073 |
2464402 - Disclosure - Commitments and contingencies (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/CommitmentsAndContingenciesDetails |
1074 |
Disclosure of finance lease and operating lease by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable |
1075 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
1076 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
1077 |
Within one year |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
1078 |
Between one and five years |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember |
1079 |
Disclosure of finance lease and operating lease by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems |
1080 |
Minimum finance lease payments payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MinimumFinanceLeasePaymentsPayable |
1081 |
Office lease expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense |
1082 |
2467401 - Disclosure - Loan and warrant (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/LoanAndWarrantDetails |
1083 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
1084 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
1085 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
1086 |
Merger |
Member |
|
|
ifrs-full:MajorBusinessCombinationMember |
1087 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
1088 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
1089 |
Warrants |
Member |
|
|
ears:StockWarrantMember |
1090 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
1091 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
1092 |
Within one year |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
1093 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
1094 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
1095 |
Secured term loan facility |
Member |
|
|
ears:LoanAndSecurityAgreementSecuredTermLoanFacilityWithHerculesCapitalInc.Member |
1096 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
1097 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
1098 |
Floating interest rate |
Member |
|
|
ifrs-full:FloatingInterestRateMember |
1099 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
1100 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
1101 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
1102 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
1103 |
Term loan facility (up to) |
Concept (Monetary) |
As Of |
Credit |
ears:LineofCreditFacilityMaximumBorrowingCapacity1 |
1104 |
Drawn on term loan facility |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
1105 |
Interest rate per annum (as a percent) |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
1106 |
Liquidity covenant amount |
Concept (Monetary) |
As Of |
Debit |
ears:LiquidityCovenantAmount |
1107 |
Repayments of current borrowings |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfCurrentBorrowings |
1108 |
Collateral cash |
Concept (Monetary) |
As Of |
Debit |
ears:CollateralCash |
1109 |
Recognized loss on loan and transaction costs |
Concept (Monetary) |
As Of |
Debit |
ears:RecognizedLossOnLoanAndTransactionCosts |
1110 |
Amortization payments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:BankBorrowingsUndiscountedCashFlows |
1111 |
Warrants issued (in shares) |
Concept (Shares) |
For Period |
|
ears:ClassofWarrantsorRightsIssued |
1112 |
Exercise price of warrants (in dollars per share) |
Concept (Share) |
As Of |
|
ears:ClassofWarrantsorRightsExercisePriceofWarrantsorRights |
1113 |
Warrants exercisable (in shares) |
Concept (Shares) |
As Of |
|
ears:ClassofWarrantsorRightsExercisable |
1114 |
Number of additional warrants exercisable upon second advance (in shares) |
Concept (Shares) |
As Of |
|
ears:ClassofWarrantsorRightsNumberofAdditionalSharesExercisable |
1115 |
Fair value of warrants |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilitiesAtFairValue |
1116 |
Gain recognized upon change in fair value of warrants |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnFinancialLiabilitiesAtFairValueThroughProfitOrLoss |
1117 |
Number of common shares exercisable through warrants, up to (in shares) |
Concept (Shares) |
For Period |
|
ears:NumberofSharesofCommonSharesExercisablebyWarrantsOutstanding |
1118 |
2470402 - Disclosure - Related party transactions (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/RelatedPartyTransactionsDetails |
1119 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
1120 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
1121 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
1122 |
Equity Incentive Plan |
Member |
|
|
ears:AurisMedicalHoldingAGLongTermEquityIncentivePlanMember |
1123 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
1124 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
1125 |
Restricted shares |
Member |
|
|
ears:RestrictedSharesMember |
1126 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
1127 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
1128 |
Executive Management |
Member |
|
|
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember |
1129 |
Board of Directors |
Member |
|
|
ears:BoardofDirectorsMember |
1130 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
1131 |
Total compensation paid to management |
Concept (Monetary) |
For Period |
Credit |
ears:PaymentsforKeyManagementPersonnelCompensation |
1132 |
Short term benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
1133 |
Post-employee benefits years |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits |
1134 |
Share-based payment charge |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
1135 |
Total |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensation |
1136 |
Number of options outstanding (in shares) |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
1137 |
Number of share options granted (in shares) |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
1138 |
Grant price (in USD per share) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
1139 |
Payroll charge |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
1140 |
Sale restriction period |
Concept (xbrli:durationItemType) |
For Period |
|
ears:SaleRestrictionPeriodForRestrictedSharesGranted |
1141 |
2473401 - Disclosure - Warrants from Public Offering (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/WarrantsFromPublicOfferingDetails |
1142 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
1143 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
1144 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
1145 |
At fair value |
Member |
|
|
ifrs-full:AtFairValueMember |
1146 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
1147 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
1148 |
Merger |
Member |
|
|
ifrs-full:MajorBusinessCombinationMember |
1149 |
Plan Name1 [Axis] |
Axis |
|
|
ears:PlanName1Axis |
1150 |
Plan Name1 [Domain] |
Member |
|
|
ears:PlanName1Domain |
1151 |
February 2017 Offering |
Member |
|
|
ears:February2017OfferingMember |
1152 |
Sale Of Stock1 [Axis] |
Axis |
|
|
ears:SaleOfStock1Axis |
1153 |
Sale Of Stock1 [Domain] |
Member |
|
|
ears:SaleOfStock1Domain |
1154 |
Public offering |
Member |
|
|
ears:PublicOfferingMember |
1155 |
Shares subject to revaluation |
Member |
|
|
ears:SharesSubjectToRevaluationMember |
1156 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
1157 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
1158 |
Series B Warrants |
Member |
|
|
ears:SeriesBWarrantsMember |
1159 |
Common shares nominal value |
Member |
|
|
ifrs-full:OrdinarySharesMember |
1160 |
Warrants |
Member |
|
|
ears:StockWarrantMember |
1161 |
Series A Warrants |
Member |
|
|
ears:SeriesAWarrantsMember |
1162 |
Warrants |
Member |
|
|
ears:WarrantsMember |
1163 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
1164 |
Number of shares issued (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
1165 |
Common shares issued (in shares) |
Concept (Shares) |
For Period |
|
ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding |
1166 |
Nominal value (in CHF per share) |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
1167 |
Conversion ratio |
Concept (Pure) |
For Period |
|
ears:ClassOfWarrantOrRightConversionRatio |
1168 |
Net proceeds after underwriting discounts |
Concept (Monetary) |
For Period |
Debit |
ears:ProceedsfromIssuingSharesNet |
1169 |
Share issue related cost |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
1170 |
Transaction costs recognized in equity |
Concept (Monetary) |
For Period |
Debit |
ears:ShareIssueRelatedCostsTransactionCosts |
1171 |
Transaction costs recognized in profit or loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FeeAndCommissionExpense |
1172 |
Period of option to purchase additional common shares and/or additional warrants |
Concept (xbrli:durationItemType) |
For Period |
|
ears:PeriodOfOptionForUnderwriterToPurchaseAdditionalEquity |
1173 |
Additional equity available for purchase (up to) (in shares) |
Concept (Shares) |
For Period |
|
ears:OptionForUnderwriterToPurchaseAdditionalEquity |
1174 |
Additional warrants purchased (in shares) |
Concept (Shares) |
For Period |
|
ears:AdditionalEquityPurchasedByUnderwriter |
1175 |
Warrants issued (in shares) |
Concept (Shares) |
For Period |
|
ears:ClassofWarrantsorRightsIssued |
1176 |
Exercise price (in USD per share) |
Concept (Share) |
As Of |
|
ears:ClassofWarrantsorRightsExercisePriceofWarrantsorRights |
1177 |
Gross proceeds |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
1178 |
Warrants outstanding |
Concept (Monetary) |
As Of |
Credit |
ears:WarrantsorRightsOutstanding1 |
1179 |
Decrease in fair value of warrants |
Concept (Monetary) |
For Period |
Credit |
ears:IncreaseDecreaseinFairValueMeasurementWarrantsorRights |
1180 |
Number of common shares exercisable through warrants, up to (in shares) |
Concept (Shares) |
For Period |
|
ears:NumberofSharesofCommonSharesExercisablebyWarrantsOutstanding |
1181 |
Exercise price of warrants (in CHF per share) |
Concept (Share) |
For Period |
|
ears:WarrantsExercisePricePerCommonShare |
1182 |
Warrants outstanding (in shares) |
Concept (Shares) |
For Period |
|
ears:WarrantsOutstanding |
1183 |
Issuance initial public offering (in shares) |
Concept (Shares) |
For Period |
|
ears:IssuanceInitialPublicOffering |
1184 |
2474401 - Disclosure - Events after the balance sheet date (Details) |
Network |
* |
* |
http://www.aurismedical.com/role/EventsAfterBalanceSheetDateDetails |
1185 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
1186 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
1187 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
1188 |
Ordinary shares |
Member |
|
|
ifrs-full:OrdinarySharesMember |
1189 |
Sale Of Stock1 [Axis] |
Axis |
|
|
ears:SaleOfStock1Axis |
1190 |
Sale Of Stock1 [Domain] |
Member |
|
|
ears:SaleOfStock1Domain |
1191 |
At-the-market Agreement |
Member |
|
|
ears:AtthemarketAgreementMember |
1192 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
1193 |
Number of shares issued (in shares) |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
1194 |
Proceeds from IPO, net of underwriting fees and IPO costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |